menu

Fireside Chats: Top Abstracts Related to Axial Manifestations in SpA

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
x
Hello, there.

Disclosures

This presentation is sponsored by Novartis Medical Affairs, and the speakers have been compensated for their time.

Laura Coates, MBChB, MRCP, PhD

  • Received honoraria, grant/research support or consultant fees: AbbVie, Amgen, Boehringer-Ingelheim, BMS, Celgene, Eli Lilly, Janssen, MSD, Novartis, Pfizer, Sun Pharma, and UCB
  • A member of a speakers' bureau for AbbVie, Amgen, Biogen, BMS, Celgene, Eli Lilly, Janssen, Medac, Novartis, Pfizer, Sun Pharma, and UCB

Alexis Ogdie-Beatty, MD, MSCE

  • Consultant: AbbVie, Amgen, Bristol Myers Squibb, Celgene, Corrona, Lilly, Novartis, Pfizer, Janssen, Gilead, UCB
  • Research grants: Novartis, Pfizer, Forward/National Databank for Rheumatic Diseases, NIH/NIAMS, Rheum Research Foundation
Read Full Program Description
CONTINUE TO PROGRAM

Fireside Chats: Top Abstracts Related to Axial Manifestations in SpA

5 chapters
Play All
Program Information
Chapters
Recommended

Program Information

Chapter 1
Fireside Chats: Top Abstracts Related to Axial Manifestations in SpA
RestartResume

Didn’t have time to attend all the key sessions at ACR Convergence 2020? Listen to the experts as they present their views on the top abstracts related to axial manifestations in SpA.

Chapter 2
video The Relative Diagnostic Utility of Inflammatory Back Pain Criteria in an Inception Cohort of Patients with Psoriasis, Iritis, and Colitis Presenting with Undiagnosed Back Pain for Segment 12209
The Relative Diagnostic Utility of Inflammatory Back Pain Criteria in an Inception Cohort of Patients with Psoriasis, Iritis, and Colitis Presenting with Undiagnosed Back Pain
Chapter 3
video Effects of Filgotinib on Spinal Lesions in Patients with Ankylosing Spondylitis: Magnetic Resonance Imaging Data from the Placebo-Controlled, Double-Blind, Randomized TORTUGA Trial for Segment 12209
Effects of Filgotinib on Spinal Lesions in Patients with Ankylosing Spondylitis: Magnetic Resonance Imaging Data from the Placebo-Controlled, Double-Blind, Randomized TORTUGA Trial
Chapter 4
video Cluster-randomized Pragmatic Clinical Trial Evaluating the Potential Benefit of a Tight-Control and Treat-to-Target Strategy in Axial Spondyloarthritis: The Results of the TICOSPA Trial for Segment 12209
Cluster-randomized Pragmatic Clinical Trial Evaluating the Potential Benefit of a Tight-Control and Treat-to-Target Strategy in Axial Spondyloarthritis: The Results of the TICOSPA Trial
Chapter 5
video Efficacy and Safety of Secukinumab in Patients with Spondyloarthritis and Enthesitis at the Achilles Tendon: 52-Weeks Results from a Randomized, Placebo-Controlled Phase 3b Trial for Segment 12209
Efficacy and Safety of Secukinumab in Patients with Spondyloarthritis and Enthesitis at the Achilles Tendon: 52-Weeks Results from a Randomized, Placebo-Controlled Phase 3b Trial
  • Sponsored by

  • Overview

    Join Dr. Laura Coates from the University of Oxford and Dr. Alexis Ogdie from the University of Pennsylvania as they walk us through the top abstracts on spondyloarthritis that were presented at ACR Convergence 2020. 

    This presentation is sponsored by Novartis Medical Affairs and all speakers have been compensated for their time.

    3/21     M-XAT-1399851​

Programs 5/13/21